[Andrenogenital syndrome (author's transl)].

Abstract

Radioimmunologically estimated diurnal profiles of 17-hydroxyprogesterone (17-OHP) showed clearly increased values in 15 patients with adrenogenital syndrome aged 9-19 years who had been treated for at least 4 1/2 years with cortisol. Increases were pronounced in the morning: at 8 hours 58.6 nmol/l, at 12 hours 22.2 nmol/l, at 18 hours 23.7 nmol/l on average. By changing cortisol medication, in particular due to split doses, morning 17-OHP peak values could be lowered and the whole daily profile could be improved: at 8 hours 17.9 nmol/l, at 12 hours 9.3 nmol/l, at 18 hours 8.1 nmol/l on average. The total cortisol dosage had to be increased only marginally from an average of 26.7 to 30 mg/m2 body surface, however, the evening dosage was increased from 20% to 38% on average of the total dose. Measurement of serum 17-OHP diurnal profile is thus advantageous in treatment of adrenogenital syndrome with cortisol when compared to values obtained from 24-hour urine collections.

• Authors: E Nieschlag, H Wenner, H Breu, E J Wickings, G Schellong
• Journal: Deutsche medizinische Wochenschrift (1946) (Dtsch Med Wochenschr) Vol. 105 Issue 17 Pg. 600-3 (Apr 25 1980) ISSN: 0012-0472 [Print] Germany
• Vernacular Title: Adrenogenitales Syndrom. Therapeutische Einstellung anhand des Tagesprofils des 17-Hydroxyprogesterons im Serum.
• PMID: 7371512 (Publication Type: English Abstract, Journal Article)

Chemical References

• Hydroxyprogesterones
• Hydrocortisone

Topics

• Adolescent
• Adrenal Hyperplasia, Congenital (blood, drug therapy)
• Adult
• Child
• Female
• Humans
• Hydrocortisone (administration & dosage, therapeutic use)
• Hydroxyprogesterones (blood)
• Male
• Radioimmunoassay
• Time Factors